Trials / Suspended
SuspendedNCT02059785
Phase ⅡStudy of Pinocembrin Injection to Treat Ischemic Stroke
Phase ⅡStudy of Pinocembrin Injection to Treat Ischemic Stroke---Randomized, Double-blind, Placebo-controlled, Multicenter Study
- Status
- Suspended
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 216 (estimated)
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Industry
- Sex
- All
- Age
- 35 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This research is a Randomized, double-blind, placebo-controlled, multicenter clinical study. Chinese subjects with Ischemic Stroke.
Detailed description
Subjects will randomly enter into one of two groups,the period of treatment is 14 days,follow-up to the 90th days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pinocembrin for Injection |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2014-02-11
- Last updated
- 2016-06-20
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02059785. Inclusion in this directory is not an endorsement.